|Title：||Patent Linkage Practice in Japan|
|Author：||Masashi SHIMURA (coauthor), 2017 Biotechnology and Life Science Committee, Subcommittee 5|
|Journal：||Patent Vol. 71, No. 10, Pages 54-65|
|Publisher：||Japan Patent Attorneys Association (JPAA)|
|Publication date：||September 10, 2018|
|Overview：||The operation of patent linkage in Japan consists of two stages, i.e., marketing approval and NHI price listing. This operation of patent linkage seems to contribute to avoid litigation. However, Japanese patent linkage is not legislated and transparent, and involves issues regarding whether it can cope with a new modality of medicines.